Top compounds associated with response to NUDT17


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 4e-07
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA VX-680 GDSC1000 pan-cancer AAC -0.21 0.0001
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA AEW541 CCLE pan-cancer AAC 0.16 0.0004
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.1 0.002
Download CSV